James R Howe
Overview
Explore the profile of James R Howe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
3908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shilyansky J, Chan C, Xiao S, Gribovskaja-Rupp I, Quelle D, Howe J, et al.
Surgery
. 2024 Dec;
179:108943.
PMID: 39665969
Objectives: Semaglutide is a glucagon-like peptide 1 (GLP-1) analog that binds to GLP-1 receptors (GLP-1R) on beta-cells and neuronal cells and is used for treating type 2 diabetes and obesity....
2.
Howe J, Sherman S, Dillon J
Ann Surg Oncol
. 2024 Dec;
32(2):1187-1188.
PMID: 39645558
No abstract available.
3.
Pieterman C, Grozinsky-Glasberg S, OToole D, Howe J, Ambrosini V, Belli S, et al.
J Neuroendocrinol
. 2024 Nov;
37(1):e13468.
PMID: 39587981
Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation...
4.
Borbon L, Sherman S, Breheny P, Chandrasekharan C, Menda Y, Bushnell D, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1193-1194.
PMID: 39578324
No abstract available.
5.
Tran C, Sherman S, Chandrasekharan C, Howe J
Hematol Oncol Clin North Am
. 2024 Nov;
39(1):37-53.
PMID: 39510676
Patients with neuroendocrine tumor liver metastases (NETLMs) may develop carcinoid syndrome, carcinoid heart disease, or other symptoms from overproduction of hormones. Hepatic resection and cytoreduction is the most direct treatment...
6.
Borbon L, Sherman S, Breheny P, Chandrasekharan C, Menda Y, Bushnell D, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1136-1148.
PMID: 39505730
Background: Peptide receptor radionuclide therapy (PRRT) is an effective treatment for advanced gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). We investigated a 2-decade experience with PRRT to determine whether PRRT confers a...
7.
Howe J, Menda Y, Chandrasekharan C, Bellizzi A, Quelle D, ODorisio M, et al.
Endocr Pract
. 2024 Sep;
31(1):4-18.
PMID: 39349242
The Iowa Neuroendocrine Tumor (NET) Clinic was founded and developed by two remarkable physicians, Thomas and Sue O'Dorisio. Tom was an Endocrinologist and close friend and colleague of Aaron Vinik....
8.
Chang J, Suraju M, Tran C, Chan C, Ear P, Howe J, et al.
J Surg Res
. 2024 Jul;
302:53-63.
PMID: 39083906
Introduction: Studies conflict on whether sex influences survival in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to female hormones. We hypothesized that women would have improved survival...
9.
Vaughn H, Major H, Kadera E, Keck K, Dunham T, Qian Q, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39062773
Functional copy-number alterations (fCNAs) are DNA copy-number changes with concordant differential gene expression. These are less likely to be bystander genetic lesions and could serve as robust and reproducible tumor...
10.
Howe J, Chan C, Lee D, Blanquart M, Lee J, Romero H, et al.
bioRxiv
. 2024 Jul;
PMID: 38979308
Animals exhibit innate behaviors that are stereotyped responses to specific evolutionarily relevant stimuli in the absence of prior learning or experience. These behaviors can be reduced to an axis of...